CHAGE 201-IPF

N/A

Report date: 2025/04/02 15:39:14

Base Information

Drug NameCHAGE 201-IPF

Drug Alias NameCHAGE 201-IPF

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCHA Biotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCHA Biotech Co Ltd

Inactive CompaniesN/A

Active IndicationsIdiopathic Pulmonary Fibrosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A